Clinical Trial Update: A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update of a personalized cancer vaccine targeting shared neoantigens for solid tumors including non-small cell lung cancer and colorectal cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Personalized cancer vaccine targeting shared neoantigens

Snippet

Sponsor: Gritstone bio, Inc. | Conditions: Non-Small Cell Lung Cancer, Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED